EARNEST Partners’s Edwards Lifesciences EW Stock Holding History

EARNEST Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30	Closed	-$2.08K	–	551
2023 Q3	$2.08K	Hold	30	–	–	﹤0.01%	990
2023 Q2	$2.83K	Hold	30	–	–	﹤0.01%	940
2023 Q1	$2.48K	Hold	30	–	–	﹤0.01%	955
2022 Q4	$2.24K	Hold	30	–	–	﹤0.01%	982
2022 Q3	$2K	Hold	30	–	–	﹤0.01%	963
2022 Q2	$3K	Sell	30 -300	-91%	-$31.1K	﹤0.01%	911
2022 Q1	$39K	Hold	330	–	–	﹤0.01%	366
2021 Q4	$43K	Sell	330 -180	-35%	-$21K	﹤0.01%	357
2021 Q3	$58K	Hold	510	–	–	﹤0.01%	323
2021 Q2	$53K	Hold	510	–	–	﹤0.01%	329
2021 Q1	$43K	Hold	510	–	–	﹤0.01%	343
2020 Q4	$47K	Hold	510	–	–	﹤0.01%	323
2020 Q3	$41K	Buy	510 +413	+426%	+$32.2K	﹤0.01%	325
2020 Q2	$7K	Sell	97 -194	-67%	-$13.8K	﹤0.01%	641
2020 Q1	$18K	Hold	291	–	–	﹤0.01%	399
2019 Q4	$23K	Hold	291	–	–	﹤0.01%	413
2019 Q3	$21K	Hold	291	–	–	﹤0.01%	430
2019 Q2	$18K	Hold	291	–	–	﹤0.01%	469
2019 Q1	$19K	Hold	291	–	–	﹤0.01%	448
2018 Q4	$15K	Hold	291	–	–	﹤0.01%	463
2018 Q3	$17K	Hold	291	–	–	﹤0.01%	458
2018 Q2	$14K	Hold	291	–	–	﹤0.01%	495
2018 Q1	$14K	Hold	291	–	–	﹤0.01%	491
2017 Q4	$11K	Buy	+291	New	+$10.7K	﹤0.01%	526
2017 Q1	–	Sell	-291	Closed	-$9K	–	452
2016 Q4	$9K	Buy	+291	New	+$9.43K	﹤0.01%	546

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

EARNEST Partners's EW Position: Q4 2023 in Review

EARNEST Partners sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 30 shares — an estimated $2.08K sold.

EARNEST Partners first reported a position in EW in Q4 2016 and held it in 25 quarters. The position peaked at $58K in Q3 2021. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

EARNEST Partners reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 30 Edwards Lifesciences shares in Q4 2023, an estimated $2.08K.
EARNEST Partners first reported a position in Edwards Lifesciences in Q4 2016 and held it in 25 quarters.
EARNEST Partners's Edwards Lifesciences position peaked at $58K in Q3 2021.
1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.